208 related articles for article (PubMed ID: 12795432)
1. Evolution of ocular manifestations in nephropathic cystinosis: a long-term study of a population treated with cysteamine.
Dureau P; Broyer M; Dufier JL
J Pediatr Ophthalmol Strabismus; 2003; 40(3):142-6. PubMed ID: 12795432
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of topical cysteamine in nephropathic cystinosis.
Al-Hemidan A; Shoughy SS; Kozak I; Tabbara KF
Br J Ophthalmol; 2017 Sep; 101(9):1234-1237. PubMed ID: 28057644
[TBL] [Abstract][Full Text] [Related]
3. [Ocular treatment of cystinosis with eye drop containing cysteamine].
Csorba A; Maka E; Szabó A; Kelen K; Reusz G; Nagy ZZ
Orv Hetil; 2022 May; 163(21):846-852. PubMed ID: 35598215
[TBL] [Abstract][Full Text] [Related]
4. Ocular manifestations of intermediate cystinosis: To treat or not to treat?
Sousa-Neves F; Ribeiro AC; Saraiva E; Ribeiro L; Sequeira J; Varandas R
Eur J Ophthalmol; 2020 Nov; 30(6):NP7-NP10. PubMed ID: 31074291
[TBL] [Abstract][Full Text] [Related]
5. A randomized clinical trial of topical cysteamine disulfide (cystamine) versus free thiol (cysteamine) in the treatment of corneal cystine crystals in cystinosis.
Iwata F; Kuehl EM; Reed GF; McCain LM; Gahl WA; Kaiser-Kupfer MI
Mol Genet Metab; 1998 Aug; 64(4):237-42. PubMed ID: 9758713
[TBL] [Abstract][Full Text] [Related]
6. Cysteamin eyedrops in three patients with nephropathic cystinosis.
Blanksma LJ; Jansonius NM; Reitsma-Bierens WC
Doc Ophthalmol; 1996-1997; 92(1):51-3. PubMed ID: 9181332
[No Abstract] [Full Text] [Related]
7. Successful use of topical cysteamine formulated from the oral preparation in a child with keratopathy secondary to cystinosis.
Khan AO; Latimer B
Am J Ophthalmol; 2004 Oct; 138(4):674-5. PubMed ID: 15488810
[TBL] [Abstract][Full Text] [Related]
8. The effect of topical cysteamine drops on reducing crystal formation within the cornea of patients affected by nephropathic cystinosis.
MacDonald IM; Noel LP; Mintsioulis G; Clarke WN
J Pediatr Ophthalmol Strabismus; 1990; 27(5):272-4. PubMed ID: 2246744
[TBL] [Abstract][Full Text] [Related]
9. Corneal crystals in nephropathic cystinosis: natural history and treatment with cysteamine eyedrops.
Gahl WA; Kuehl EM; Iwata F; Lindblad A; Kaiser-Kupfer MI
Mol Genet Metab; 2000; 71(1-2):100-20. PubMed ID: 11001803
[TBL] [Abstract][Full Text] [Related]
10. Photophobia and corneal crystal density in nephropathic cystinosis: an in vivo confocal microscopy and anterior-segment optical coherence tomography study.
Liang H; Baudouin C; Tahiri Joutei Hassani R; Brignole-Baudouin F; Labbe A
Invest Ophthalmol Vis Sci; 2015 May; 56(5):3218-25. PubMed ID: 26024106
[TBL] [Abstract][Full Text] [Related]
11. Nephropathic cystinosis: posterior segment manifestations and effects of cysteamine therapy.
Tsilou ET; Rubin BI; Reed G; Caruso RC; Iwata F; Balog J; Gahl WA; Kaiser-Kupfer MI
Ophthalmology; 2006 Jun; 113(6):1002-9. PubMed ID: 16603246
[TBL] [Abstract][Full Text] [Related]
12. Nephropathic cystinosis in children: An overlooked disease.
Soliman NA; El-Baroudy R; Rizk A; Bazaraa H; Younan A
Saudi J Kidney Dis Transpl; 2009 May; 20(3):436-42. PubMed ID: 19414947
[TBL] [Abstract][Full Text] [Related]
13. Intravenous delivery of cysteamine for the treatment of cystinosis: association with hepatotoxicity.
Bendel-Stenzel MR; Steinke J; Dohil R; Kim Y
Pediatr Nephrol; 2008 Feb; 23(2):311-5. PubMed ID: 17668247
[TBL] [Abstract][Full Text] [Related]
14. Ocular changes in nephropathic cystinosis: The course of the gold-dust.
Flockerzi E; Daas L; Schlötzer-Schrehardt U; Zimpfer A; Bohle R; Seitz B
Int Ophthalmol; 2019 Jun; 39(6):1413-1418. PubMed ID: 29916124
[TBL] [Abstract][Full Text] [Related]
15. Cysteamine therapy delays the progression of nephropathic cystinosis in late adolescents and adults.
Brodin-Sartorius A; Tête MJ; Niaudet P; Antignac C; Guest G; Ottolenghi C; Charbit M; Moyse D; Legendre C; Lesavre P; Cochat P; Servais A
Kidney Int; 2012 Jan; 81(2):179-89. PubMed ID: 21900880
[TBL] [Abstract][Full Text] [Related]
16. Ocular manifestations of nephropathic cystinosis. The French-Canadian experience in a genetically homogeneous population.
Richler M; Milot J; Quigley M; O'Regan S
Arch Ophthalmol; 1991 Mar; 109(3):359-62. PubMed ID: 2003795
[TBL] [Abstract][Full Text] [Related]
17. Early oral cysteamine therapy for nephropathic cystinosis.
Gahl WA
Eur J Pediatr; 2003 Dec; 162 Suppl 1():S38-41. PubMed ID: 14610675
[TBL] [Abstract][Full Text] [Related]
18. Follow-up and treatment of adults with cystinosis in the Netherlands.
Geelen JM; Monnens LA; Levtchenko EN
Nephrol Dial Transplant; 2002 Oct; 17(10):1766-70. PubMed ID: 12270982
[TBL] [Abstract][Full Text] [Related]
19. Removal of corneal crystals by topical cysteamine in nephropathic cystinosis.
Kaiser-Kupfer MI; Fujikawa L; Kuwabara T; Jain S; Gahl WA
N Engl J Med; 1987 Mar; 316(13):775-9. PubMed ID: 3821824
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
